CDC\u2019s Investments to Combat Antibiotic Resistance Threats Nationwide : Florida

$1,344,327 Funding for AR Activities Fiscal Year 2017Candida auris, a resistant fungus that can cause deadly infections, was identified in Florida. CDC provides Florida with resources to identify and contain resistant infections, like C. auris. After C. auris emerged in the U.S. in 2016, the AR Lab Network regional labs also began providing specialized testing to states fighting this new threat.Funding to local health departments:$386,615 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, Florida supported multiple outbreak responses, including reports of a C. difficile infection cluster and OXA-48 Klebsiella pneumonia case. The HAI/AR program reviewed infection prevention practices and recommended ways to improve prevention, antibiotic use and surveillance for \u201cnightmare bacteria\u201d CRE transmission.$682,804 - HAI/AR PREVENTION works best when public health and healthcare facilities partner together to implement targeted, coordinated strategies to stop infections and improve antibiotic use. With 2016 funding, Florida is working to establish a collaborative of healthcare providers to coordinate prevention efforts around CRE, a family of bacteria that are difficult to treat because they have high levels of antibiotic resistance.$224,908 - FOOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. Florida implemented whole genome sequencing of Listeria, Salmonella, Campylobacter and E. coli isolates submitted to its lab and began uploading sequence data into PulseNet for nationwide monitoring of outbreaks and trends. In Fiscal Year 2018, Florida will begin simultaneously monitoring these isolates for resistance genes. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread.$50,000 - GONORRHEA RAPID DETECTION & RESPONSE works with state and local epidemiology and laboratory partners to test for and quickly respond to resistant gonorrhea to stop its spread in high risk communities. Only one treatment option remains for gonorrhea and resistance continues to grow.Publication date from document properties.Florida-2017-CDC-AR-Investments.pd